Literature DB >> 15821902

Studies of variations of the cyclin-dependent kinase inhibitor 1C and the cyclin-dependent kinase 4 genes in relation to type 2 diabetes mellitus and related quantitative traits.

Eva-Maria D Nielsen1, Lars Hansen, Trine Stissing, Keiko Yanagisawa, Knut Borch-Johnsen, Pernille Poulsen, Allan Vaag, Torben Hansen, Oluf Pedersen.   

Abstract

CDK4 is involved in the regulation of body weight, pancreatic beta-cell proliferation, insulin responsiveness, and diabetes pathogenesis. CDK4 activity is inhibited by CDKN1C, which is regulated by insulin. In addition, CDKN1C plays an important role in beta-cell proliferation and is involved in the pathogenesis of the Beckwith-Wiedemann syndrome, a disorder characterized by neonatal hyperinsulinaemic hypoglycaemia and pre- and post-natal overgrowth. The aim of this study was to investigate if variations in the proximal promoter and the coding region of the CDKN1C and CDK4 genes are associated with type 2 diabetes or changes in related quantitative phenotypes among glucose-tolerant subjects. Mutation analyses of the two genes in 62 type 2 diabetic patients resulted in the discovery of seven variants of CDKN1C and two variants of CDK4. In a case-control study comprising 717 type 2 diabetic patients and 518 glucose-tolerant subjects the most frequent variants did not show any difference in allele frequencies between the type 2 diabetic patients and the control subjects. However, in two genotype-quantitative trait correlation studies involving 206 glucose-tolerant offspring of type 2 diabetic patients and 359 young, healthy subjects the CDKN1C del171APVA variant associated with increased birth weight (P=0.05 and P=0.05). Furthermore, the same variant tended to be associated with decreased basal glucose oxidation among 16 genotypically discordant dizygotic twins (P=0.03). In a genotype-quantitative trait study involving 500 middle-aged glucose-tolerant subjects the CDK4 IVS2-31G-->A variant was associated with an increased waist circumference (P=0.03) and waist-to-hip ratio (P=0.02) and altered fasting plasma glucose (P=0.03). However, these later findings could not be replicated in additional studies. In conclusion, variants in CDKN1C may contribute to the inter-individual variation in birth weight.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15821902     DOI: 10.1007/s00109-005-0647-3

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  37 in total

1.  Low frequency of p57KIP2 mutation in Beckwith-Wiedemann syndrome.

Authors:  M P Lee; M DeBaun; G Randhawa; B A Reichard; S J Elledge; A P Feinberg
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

2.  Age-dependent impact of zygosity and birth weight on insulin secretion and insulin action in twins.

Authors:  P Poulsen; K Levin; H Beck-Nielsen; A Vaag
Journal:  Diabetologia       Date:  2002-11-09       Impact factor: 10.122

Review 3.  Beckwith-Wiedemann syndrome.

Authors:  M Elliott; E R Maher
Journal:  J Med Genet       Date:  1994-07       Impact factor: 6.318

4.  Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors.

Authors:  J O Clausen; K Borch-Johnsen; H Ibsen; R N Bergman; P Hougaard; K Winther; O Pedersen
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

5.  Analysis of germline CDKN1C (p57KIP2) mutations in familial and sporadic Beckwith-Wiedemann syndrome (BWS) provides a novel genotype-phenotype correlation.

Authors:  W W Lam; I Hatada; S Ohishi; T Mukai; J A Joyce; T R Cole; D Donnai; W Reik; P N Schofield; E R Maher
Journal:  J Med Genet       Date:  1999-07       Impact factor: 6.318

6.  Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5.

Authors:  A Koufos; P Grundy; K Morgan; K A Aleck; T Hadro; B C Lampkin; A Kalbakji; W K Cavenee
Journal:  Am J Hum Genet       Date:  1989-05       Impact factor: 11.025

7.  Assessment of p57(KIP2) gene mutation in Beckwith-Wiedemann syndrome.

Authors:  V Gaston; Y Le Bouc; V Soupre; M P Vazquez; C Gicquel
Journal:  Horm Res       Date:  2000

Review 8.  Cyclin D-dependent kinases, INK4 inhibitors and cancer.

Authors:  Sagrario Ortega; Marcos Malumbres; Mariano Barbacid
Journal:  Biochim Biophys Acta       Date:  2002-03-14

9.  Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse.

Authors:  I Hatada; T Mukai
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

Review 10.  Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer.

Authors:  T K MacLachlan; N Sang; A Giordano
Journal:  Crit Rev Eukaryot Gene Expr       Date:  1995       Impact factor: 1.807

View more
  4 in total

1.  Is imprinting in printing or in press?

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2005-05       Impact factor: 4.599

Review 2.  Cycling through metabolism.

Authors:  Victor Aguilar; Lluis Fajas
Journal:  EMBO Mol Med       Date:  2010-09       Impact factor: 12.137

3.  Germline and somatic imprinting in the nonhuman primate highlights species differences in oocyte methylation.

Authors:  Clara Y Cheong; Keefe Chng; Shilen Ng; Siew Boom Chew; Louiza Chan; Anne C Ferguson-Smith
Journal:  Genome Res       Date:  2015-04-10       Impact factor: 9.043

4.  The type 2 diabetes associated minor allele of rs2237895 KCNQ1 associates with reduced insulin release following an oral glucose load.

Authors:  Johan Holmkvist; Karina Banasik; Gitte Andersen; Hiroyuki Unoki; Thomas Skot Jensen; Charlotta Pisinger; Knut Borch-Johnsen; Annelli Sandbaek; Torsten Lauritzen; Sören Brunak; Shiro Maeda; Torben Hansen; Oluf Pedersen
Journal:  PLoS One       Date:  2009-06-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.